BAX logo

BAX Baxter International Inc.

New York Stock Exchange · Medical - Instruments & Supplies · Healthcare

$26.16
+0.40 (+1.55%)

Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devic…

Market Cap: $13.53Bwww.baxter.com

Price

No data yet.

Social Signal Score

60
5d
60
1 mentions
—
30d
63
8 mentions
—
60d
57
14 mentions
—
90d
59
16 mentions
—
news: 13 · marketaux: 1 · rss: 2

Analyst Ratings

36 analysts
Holdconsensus
Strong Buy 0Buy 14Hold 20Sell 2Strong Sell 0
Avg price target$23.83-8.9%
Low $20Median $24.5High $28
Current Consensus

Revenue

$2.98B+12.51%
$2.48B$2.95B$3.42B$3.89B
Dec 2016Sep 2026

Analyst Estimates

FY2025
$2.37
$2.36–$2.39
12 analysts
FY2026
$2.11-11% YoY
$2.06–$2.13
10 analysts
FY2027
$2.04-3% YoY
$1.75–$2.13
10 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Andrew Hider
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
37,500
Beta
0.67
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
2.45
www.baxter.com